Outcomes of patients with myelodysplastic syndromes who achieve stable disease after treatment with hypomethylating agents

Leukemia Research
Aziz NazhaMDS Clinical Research Consortium

Abstract

Treatment with hypomethylating agents (HMAs) improves overall survival (OS) in patients who achieve a response of stable disease (SD) or better (complete remission [CR], partial remission [PR], or hematologic improvement [HI]). It is not well established if patients who achieve SD at 4-6 months of therapy should be offered different therapies to optimize their response or continue with the same regimen. Clinical data were obtained from the MDS Clinical Research Consortium database. SD was defined as no evidence of progression and without achievement of any other responses. Of 291 patients treated with AZA or DAC, 55% achieved their best response (BR) at 4-6 months. Among patients with SD at 4-6 months, 29 (20%) achieved a better response at a later treatment time point. Younger patients with lower bone marrow blast percentages, and intermediate risk per IPSS-R were more likely to achieve a better response (CR, PR, or HI) after SD at 4-6 months. Patients with SD who subsequently achieved CR had superior OS compared to patients who remained with SD (28.1 vs. 14.4 months, respectively, p=.04). In conclusion, patients treated with HMAs who achieves CR after a SD status had longer survival with continuous treatment after 6 months.

References

May 16, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lewis R SilvermanJames F Holland
May 30, 2013·American Society of Clinical Oncology Educational Book·Rafael BejarRami S Komrokji
Dec 24, 2013·Blood·Mikkael A Sekeres, Corey Cutler
Jan 28, 2014·American Journal of Hematology·Guillermo Garcia-Manero

❮ Previous
Next ❯

Citations

Sep 14, 2016·Journal of Oncology Practice·Vijaya Raj Bhatt, David P Steensma
Oct 27, 2017·Expert Review of Hematology·Roberto CastelliGiorgio Lambertenghi-Deliliers
Jun 8, 2017·Blood·Eytan M SteinMartin S Tallman
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Rami S Komrokji
Jun 2, 2020·Expert Review of Anticancer Therapy·Jonathan FeldShyamala C Navada
Mar 1, 2019·Proceedings of the National Academy of Sciences of the United States of America·Shuvojit BanerjeeRobert H Silverman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Auditory Perception

Auditory perception is the ability to receive and interpret information attained by the ears. Here is the latest research on factors and underlying mechanisms that influence auditory perception.